Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytosorbents Corporation - Common Stock (NQ:CTSO)

1.100 +0.000 (+0.01%)
Streaming Delayed Price Updated: 1:29 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,035
Open 1.080
Bid (Size) 1.100 (1)
Ask (Size) 1.120 (2)
Prev. Close 1.100
Today's Range 1.080 - 1.120
52wk Range 0.7101 - 1.610
Shares Outstanding 54,679,569
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Demystifying CytoSorbents: Insights From 5 Analyst Reviews
 
Via Benzinga
CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss
CytoSorbents (CTSO) reported Q2 2025 results with revenue of $9.62M, beating estimates, and a narrower EPS loss of -$0.05. Shares rose 4.32% post-earnings amid steady demand for CytoSorb. 
Via Chartmill

Performance

YTD
+19.6%
+19.6%
1 Month
+5.8%
+5.8%
3 Month
+29.4%
+29.4%
6 Month
-6.8%
-6.8%
1 Year
+4.8%
+4.8%

More News

Read More
Earnings Scheduled For August 7, 2025
Via Benzinga
A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts
Via Benzinga
Top movers in Wednesday's session
Via Chartmill
CytoSorbents's Earnings: A Preview
Via Benzinga
Insights into CytoSorbents's Upcoming Earnings
Via Benzinga
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Gapping stocks in Wednesday's session
Via Chartmill
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Demystifying CytoSorbents: Insights From 4 Analyst Reviews
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts
Via Benzinga
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
From CytoSorbents
Via GlobeNewswire
Earnings Scheduled For May 14, 2025
Via Benzinga
Earnings Scheduled For March 31, 2025
Via Benzinga
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
From CytoSorbents
Via GlobeNewswire
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
From CytoSorbents
Via GlobeNewswire
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
From CytoSorbents
Via GlobeNewswire
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
From CytoSorbents
Via GlobeNewswire
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
Via Benzinga
Topics Supply Chain
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
From CytoSorbents
Via GlobeNewswire
CytoSorbents Rights Offering Begins
From CytoSorbents
Via GlobeNewswire

Frequently Asked Questions

Is Cytosorbents Corporation - Common Stock publicly traded?
Yes, Cytosorbents Corporation - Common Stock is publicly traded.
What exchange does Cytosorbents Corporation - Common Stock trade on?
Cytosorbents Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytosorbents Corporation - Common Stock?
The ticker symbol for Cytosorbents Corporation - Common Stock is CTSO on the Nasdaq Stock Market
What is the current price of Cytosorbents Corporation - Common Stock?
The current price of Cytosorbents Corporation - Common Stock is 1.100
When was Cytosorbents Corporation - Common Stock last traded?
The last trade of Cytosorbents Corporation - Common Stock was at 08/19/25 01:29 PM ET
What is the market capitalization of Cytosorbents Corporation - Common Stock?
The market capitalization of Cytosorbents Corporation - Common Stock is 60.15M
How many shares of Cytosorbents Corporation - Common Stock are outstanding?
Cytosorbents Corporation - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.